Press releasePRNewswire
Futurewave Acquisition
FWAC · NASDAQ
$9.97+$0.02 (+0.20%)TodayMarket closed ·
Prev close $9.95
About FWAC
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Jun 25, 2026
- Sector
- N/A
- Industry
- N/A
FWAC key statistics
- Market cap
- 128.01M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 40.93K
- Volume
- 8.23K
- Open price
- $10.01
- High today
- $9.97
- Low today
- $9.96
- 52 Week high
- $9.96
- 52 Week low
- $9.85
Futurewave Acquisition (FWAC) at a glance
Futurewave Acquisition (FWAC) last traded at $9.97, with a market cap of 128.01M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $9.96 and $9.97. The current price is 0.1% above the day's low and 0.0% below its high.
Volume so far is 8.23K shares, below the average of 40.93K shares a day.
Over the past year Futurewave Acquisition has ranged from $9.85 to $9.96, and now sits 109% of the way up that range.
FWAC news
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Futurewave Acquisition Corporation (NASDAQ: FWAC)
Most active stocks
Highest trading volume today
- INLFINLIF$0.2899+56.70%
- RBNERobin Energy$0.151+8.95%
- GMZPGemz$0.0001−50.00%
- INTCIntel$59.97−8.80%
- INOInovio Pharmaceuticals$1.90+215.31%
- XXII22nd Century Group$0.0741+6.47%
- NVDGraniteShares ETF Trust$4.54+2.60%
- TMGITransglobal Management Group$0.0001−33.33%
- BDMDBaird Medical Investment Holdings$0.138−13.97%
- SOXLDirexion Shares ETF Trust$68.17−11.52%
- RDARRaadr$0.0002+0.00%
- EARIEntertainment Arts Research$0.0002+0.00%
Newly listed
Companies that went public in the past six weeks
- GBCGEORGIA BANKING$37.28−2.87%
- BHAIUBHAV Acquisition Corp II$10.00+0.15%
- SCQCUSPACCircle Acquisition$9.97−0.15%
- LYCALycia Therapeutics$27.18+2.95%
- DAVIDAVION HEALTHCARE$1.49−11.31%
- TCXBTCGX Acquisition Corp. II$10.10−0.39%
- CTYCITY THERAPEUTICS$20.88+0.82%
- IAMIambic Therapeutics$12.96−3.54%
- AMROAmaero$5.72+2.88%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.16−0.10%
- TRXBTRex Bio$13.64−0.73%
- RTSNRetension Pharmaceuticals$11.30−0.53%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.